CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts as a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. (2024). International Journal of Medical Science Research and Development (ISCSITR-IJMSRD), 5(2), 1-9. https://iscsitr.in/index.php/ISCSITR-IJMSRD/article/view/ISCSITR-IJMSRD_05_02_001